Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Heymann

Showing results (121-130 of 243) with videos related to

Pageof 25
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2004
Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3Céline Chipoy, Martine Berreur, Séverine Couillaud, et al.
Biochimica Et Biophysica Acta|February 10, 2015
Syndecan-1 regulates the biological activities of interleukin-34Aude I Segaliny, Regis Brion, Erwan Mortier, et al.
Plos One|May 19, 2011
Distinct roles of Bcl-2 and Bcl-Xl in the apoptosis of human bone marrow mesenchymal stem cells during differentiationLisa Oliver, Erika Hue, Julien Rossignol, et al.
Biochemical Pharmacology|May 6, 2023
Pharmacological options in the treatment of osteogenesis imperfecta: A comprehensive review of clinical and potential alternativesJavier Muñoz-Garcia, Dominique Heymann, Irina Giurgea, et al.
Journal of Bone Oncology|August 22, 2022
Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patientsClément J F Heymann, Christine Bobin-Dubigeon, Javier Muñoz-Garcia, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 7, 2014
Novel RANK antagonists for the treatment of bone-resorptive disease: theoretical predictions and experimental validationStéphane Téletchéa, Verena Stresing, Soizic Hervouet, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2011
Impact of oncopediatric dosing regimen of zoledronic acid on bone growth: preclinical studies and case report of an osteosarcoma pediatric patientSéverine Battaglia, Sophie Dumoucel, Julie Chesneau, et al.
European Journal of Human Genetics : EJHG|September 12, 2013
Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfectaJulie Rousseau, Roberta Gioia, Pierre Layrolle, et al.
Cancers|June 28, 2023
Spatial Distribution of Immune Cells in Primary and Recurrent Glioblastoma: A Small Case StudyDelphine Loussouarn, Lisa Oliver, Celine Salaud, et al.
BMC Cancer|March 12, 2014
Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing's sarcoma via inhibition of cell migrationGuillaume Odri, Pui-Pui Kim, François Lamoureux, et al.
Pageof 25

Showing results (121-130 of 243) with videos related to

Sort By:
Pageof 25
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 13, 2004
Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3Céline Chipoy, Martine Berreur, Séverine Couillaud, et al.
Biochimica Et Biophysica Acta|February 10, 2015
Syndecan-1 regulates the biological activities of interleukin-34Aude I Segaliny, Regis Brion, Erwan Mortier, et al.
Plos One|May 19, 2011
Distinct roles of Bcl-2 and Bcl-Xl in the apoptosis of human bone marrow mesenchymal stem cells during differentiationLisa Oliver, Erika Hue, Julien Rossignol, et al.
Biochemical Pharmacology|May 6, 2023
Pharmacological options in the treatment of osteogenesis imperfecta: A comprehensive review of clinical and potential alternativesJavier Muñoz-Garcia, Dominique Heymann, Irina Giurgea, et al.
Journal of Bone Oncology|August 22, 2022
Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patientsClément J F Heymann, Christine Bobin-Dubigeon, Javier Muñoz-Garcia, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 7, 2014
Novel RANK antagonists for the treatment of bone-resorptive disease: theoretical predictions and experimental validationStéphane Téletchéa, Verena Stresing, Soizic Hervouet, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 30, 2011
Impact of oncopediatric dosing regimen of zoledronic acid on bone growth: preclinical studies and case report of an osteosarcoma pediatric patientSéverine Battaglia, Sophie Dumoucel, Julie Chesneau, et al.
European Journal of Human Genetics : EJHG|September 12, 2013
Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfectaJulie Rousseau, Roberta Gioia, Pierre Layrolle, et al.
Cancers|June 28, 2023
Spatial Distribution of Immune Cells in Primary and Recurrent Glioblastoma: A Small Case StudyDelphine Loussouarn, Lisa Oliver, Celine Salaud, et al.
BMC Cancer|March 12, 2014
Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing's sarcoma via inhibition of cell migrationGuillaume Odri, Pui-Pui Kim, François Lamoureux, et al.
Pageof 25